The National Investigational New Animal Drug Program is operated by the Aquatic Animal Drug Approval Partnership. It is the only program in the United States singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new medications needed for use in fish culture and fisheries management. Since the late 1990’s, Aquatic Animal Drug Approval Partnership Program has contributed to the majority of the new fish medications approved by the FDA.